69 phenotypes from 15 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Myh9Gt(Betageo-btk)1Dash/Myh9+ involves: 129X1/SvJ * C57BL/6	normal hematopoietic system phenotype	J:94067
	impaired hearing	J:94067
	increased or absent threshold for auditory brainstem response	J:94067
	normal renal/urinary system phenotype	J:94067
Myh9Gt(Betageo-btk)1Dash/Myh9Gt(Betageo-btk)1Dash involves: 129X1/SvJ * C57BL/6	embryonic lethality between implantation and somite formation, complete penetrance	J:94067
Myh9Gt(RRE342)Byg/Myh9+ involves: 129P2/OlaHsd * C57BL/6	no abnormal phenotype detected	J:110432
Myh9Gt(RRE342)Byg/Myh9Gt(RRE342)Byg involves: 129P2/OlaHsd * C57BL/6	prenatal lethality, complete penetrance	J:110432
Myh9tm1(mCherry/MYH9)Rsad/Myh9tm1(mCherry/MYH9)Rsad involves: 129S4/SvJae * C57BL/6	no abnormal phenotype detected	J:163702
Myh9tm1.1(MYH9*)Mjk/Myh9+ B6.Cg-Myh9tm1.1(MYH9*)Mjk	abnormal eye physiology	J:175367
	abnormal lens fiber morphology	J:175367
	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	albuminuria	J:175367
	cataract	J:175367
	corneal vascularization	J:175367
	increased bleeding time	J:175367
	increased incidence of corneal inflammation	J:175367
	increased or absent threshold for auditory brainstem response	J:175367
	increased susceptibility to age-related hearing loss	J:175367
	thrombocytopenia	J:175367
Myh9tm1.1(MYH9*)Mjk/Myh9tm1.1(MYH9*)Mjk B6.129-Myh9tm1.1(MYH9*)Mjk	abnormal megakaryocyte morphology	J:175367
	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	albuminuria	J:175367
	glomerulosclerosis	J:175367
	increased bleeding time	J:175367
	thrombocytopenia	J:175367
Myh9tm1.1Dash/Myh9+ involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA	abnormal lens fiber morphology	J:204923
	abnormal megakaryocyte differentiation	J:204923
	abnormal platelet morphology	J:204923
	abnormal thrombopoiesis	J:204923
	albuminuria	J:204923
	glomerulosclerosis	J:204923
	normal hearing/vestibular/ear phenotype	J:204923
	hematuria	J:204923
	normal homeostasis/metabolism phenotype	J:204923
	increased or absent threshold for auditory brainstem response	J:204923
	podocyte foot process effacement	J:204923
	preweaning lethality, complete penetrance	J:204923
	thrombocytopenia	J:204923
	normal vision/eye phenotype	J:204923
Myh9tm1.1Dash/Myh9tm1.1Dash involves: 129S2/SvPas * C57BL/6 * CBA	prenatal lethality, complete penetrance	J:204923
Myh9tm1.1Gac/Myh9+ Tg(Pf4-icre)Q3Rsko/0 involves: 129 * C57BL/6	abnormal platelet physiology	J:148233
Myh9tm1.1Gac/Myh9tm1.1Gac Tg(NPHS2-cre)295Lbh/0 involves: 129 * C57BL/6 * SJL	albuminuria	J:173971
	normal cardiovascular system phenotype	J:173971
	fused podocyte foot processes	J:173971
	glomerulosclerosis	J:173971
	normal growth/size/body region phenotype	J:173971
	normal homeostasis/metabolism phenotype	J:173971
	increased renal glomerulus basement membrane thickness	J:173971
	increased susceptibility to injury	J:173971
	podocyte foot process effacement	J:173971
	podocyte microvillus transformation	J:173971
	renal cast	J:173971
	normal renal/urinary system phenotype	J:173971
Myh9tm1.1Gac/Myh9tm1.1Gac Tg(Pf4-icre)Q3Rsko/0 involves: 129 * C57BL/6	abnormal blood coagulation	J:148233
	abnormal platelet morphology	J:148233
	abnormal platelet physiology	J:148233
	abnormal platelet shape	J:148233
	increased bleeding time	J:148233
	increased susceptibility to induced morbidity/mortality	J:148233
	thrombocytopenia	J:148233
Myh9tm1.2Gac/Myh9tm1.2Gac involves: 129	normal hematopoietic system phenotype	J:195436
Myh9tm1Maco/Myh9tm1Maco involves: 129X1/SvJ	abnormal germ layer development	J:94940, J:163702
	abnormal visceral endoderm morphology	J:94940, J:163702
	embryonic lethality between implantation and somite formation, complete penetrance	J:94940, J:163702
	failure to gastrulate	J:163702
Myh9tm2(GFP/MYH10)Rsad/Myh9tm2(GFP/MYH10)Rsad involves: 129S4/SvJae * C57BL/6	abnormal actin cytoskeleton morphology	J:163702
	abnormal brain vasculature morphology	J:163702
	abnormal cell adhesion	J:163702
	abnormal cell migration	J:163702
	abnormal placenta labyrinth morphology	J:163702
	abnormal placenta morphology	J:163702
	abnormal placenta size	J:163702
	abnormal placental labyrinth vasculature morphology	J:163702
	abnormal spongiotrophoblast layer morphology	J:163702
	abnormal vascular branching morphogenesis	J:163702
	abnormal vitelline vasculature morphology	J:163702
	normal embryo phenotype	J:163702
	embryonic growth retardation	J:163702
	embryonic lethality during organogenesis, complete penetrance	J:163702
	pale yolk sac	J:163702
Myh9tm3(GFP/MYH9/MYH10)Rsad/Myh9tm3(GFP/MYH9/MYH10)Rsad involves: 129S4/SvJae * C57BL/6	abnormal actin cytoskeleton morphology	J:163702
	abnormal cell adhesion	J:163702
	abnormal cell migration	J:163702
	abnormal placental labyrinth vasculature morphology	J:163702
	abnormal vitelline vasculature morphology	J:163702
	normal embryo phenotype	J:163702
	embryonic lethality during organogenesis, complete penetrance	J:163702
	pale yolk sac	J:163702
	thin placenta labyrinth	J:163702
Myh9tm4(GFP/MYH10/MYH9)Rsad/Myh9tm4(GFP/MYH10/MYH9)Rsad involves: 129S4/SvJae * C57BL/6	abnormal actin cytoskeleton morphology	J:163702
	abnormal cell adhesion	J:163702
	abnormal cell migration	J:163702
	abnormal placenta labyrinth morphology	J:163702
	abnormal placenta morphology	J:163702
	abnormal placenta size	J:163702
	abnormal placental labyrinth vasculature morphology	J:163702
	abnormal spongiotrophoblast layer morphology	J:163702
	abnormal vitelline vasculature morphology	J:163702
	normal embryo phenotype	J:163702
	embryonic lethality during organogenesis, complete penetrance	J:163702
	pale yolk sac	J:163702
Myh9tm5Rsad/Myh9tm5Rsad involves: 129S6/SvEvTac * C57BL/6J	abnormal leukocyte migration	J:164684
	abnormal T cell physiology	J:164684
Myh9tm5Rsad/Myh9tm5Rsad Tg(Lck-cre)#Nik/0 involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2	abnormal CD8-positive, alpha-beta T cell physiology	J:164684
	abnormal leukocyte adhesion	J:164684
	abnormal leukocyte migration	J:164684
	abnormal lymph node cell ratio	J:164684
	abnormal T cell physiology	J:164684
	decreased CD8-positive, alpha-beta T cell number	J:164684
Myh9tm5Rsad/Myh9tm5Rsad Tg(Nphs2-cre)1Seq/0 involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ	abnormal podocyte morphology	J:175367
	albuminuria	J:175367
	glomerulosclerosis	J:175367
	podocyte foot process effacement	J:175367
Myh9tm6.1(EGFP/MYH9*)Rsad/Myh9+ involves: 129S4/SvJae * BALB/cJ * C57BL/6	abnormal blood coagulation	J:175367
	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	increased bleeding time	J:175367
	increased megakaryocyte cell number	J:175367
	thrombocytopenia	J:175367
Myh9tm6.1(EGFP/MYH9*)Rsad/Myh9tm6.1(EGFP/MYH9*)Rsad involves: 129S4/SvJae * BALB/cJ * C57BL/6	abnormal placenta fetal blood space morphology	J:175367
	abnormal placenta intervillous maternal lacunae morphology	J:175367
	decreased embryo size	J:175367
	embryonic growth retardation	J:175367
	embryonic lethality during organogenesis, complete penetrance	J:175367
Myh9tm7.1Rsad/Myh9+ involves: BALB/cJ	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	albuminuria	J:175367
	cataract	J:175367
	glomerulosclerosis	J:175367
	increased bleeding time	J:175367
	increased megakaryocyte cell number	J:175367
	thrombocytopenia	J:175367
Myh9tm7.1Rsad/Myh9tm7.1Rsad involves: BALB/cJ	abnormal megakaryocyte morphology	J:175367
	abnormal neutrophil morphology	J:175367
	abnormal platelet morphology	J:175367
	albuminuria	J:175367
	cataract	J:175367
	glomerulosclerosis	J:175367
	increased bleeding time	J:175367
	increased megakaryocyte cell number	J:175367
	thrombocytopenia	J:175367
Myh9tm8.1Rsad/Myh9+ involves: BALB/cJ	glomerulosclerosis	J:175367